Sign in
4

Changes in Ownership

Outlook Therapeutics, Inc. Filed Acc 0001209191-22-053354

Director bought 33,343 shares at an average $1.29 ($42,940)

From the SEC's structured data for this filing

Trades in this filing

Haddadin Yezan Munther · Director

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2022-10-06 Purchase : show line 1 in the form +29,743 $1.29 $38,368 59,743 D
2022-10-07 Purchase : show line 2 in the form +3,600 $1.27 $4,572 63,343 D
Open-market purchases · 33,343 sh · avg $1.29 · $42,940
Loading xslF345X03/doc4.xml…